Solid Biosciences Inc. — Director's Dealing 2022

Dec 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-12-02

Reporting Person: Herzich Paul (Chief Technology Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-02	Stock Option (Right to Buy)	$6.77	A	57900	Acquired	2032-12-02	Common Stock (57900)	Direct
2022-12-02	Restricted Stock Units	$	A	28955	Acquired		Common Stock (28955)	Direct

Footnotes

F1: This option was granted on December 2, 2022 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.